Ignite Creation Date:
2025-12-24 @ 9:32 PM
Ignite Modification Date:
2026-03-04 @ 8:27 PM
Study NCT ID:
NCT00964132
Status:
UNKNOWN
Last Update Posted:
2009-09-03
First Post:
2009-08-20
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Oral NRX 194204 Study in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)
Sponsor:
NuRx Pharmaceuticals, Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
194204-203
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Roshantha A. Chandraratna, PhD, MBA, Chief Scientific Officer
Old Organization:
NuRx Pharmaceuticals